Sublicensing Fees. At such times from time to time as Company may receive Sublicensing Fees, Company will pay a portion thereof to Licensor, as follows:
(a) If the Sublicensing Fee is paid pursuant to a sublicense agreement which was signed and legally binding on both Company and the Sublicensee prior to the date when there was an approved NDA in the United States (or its equivalent in a Major Market) for the Product for which the Sublicensing Fee is received by Company, then Company shall pay to Licensor [*]% of said Sublicensing Fee; payable within [*] ([*]) days after Company’s receipt thereof.
(b) If the Sublicensing Fee is paid pursuant to a sublicense agreement which was signed and legally binding on both Company and the Sublicensee after the date when there was an approved NDA in the United States (or its equivalent in a Major Market) for the Product for which the Sublicensing Fee is received by Company, then Company shall pay to Licensor [*]% of said Sublicensing Fee; payable within [*] ([*]) days after Company’s receipt thereof.
Sublicensing Fees. Licensee will pay Foundation a portion of the Sublicensing Revenues (“Sublicensing Fees”) in accordance with the following schedule: Prior to [***] [***] for the first Product [***] After the [***] [***] for the first Product, but prior to [***] [***] After the [***] [***] [***] [***] Payments shall be made to Foundation within thirty (30) days of receipt by Licensee.
Sublicensing Fees. Licensee will pay Foundation twenty-five percent (25%) of Sublicensing Fees, subject to Section 3.5(d).
Sublicensing Fees. Sublicensing Fees equal to a percentage of any revenue not based on product sales that LICENSEE or SUBLICENSEES (or a designee) is due from or receives from SUBLICENSEES or assignees in consideration for rights under or relating to the PATENT RIGHTS (e.g., license issue fees, maintenance or annual minimum fees, milestone payments, other royalties), but excluding, (a) amounts received for the purchase of securities; (b) payments of loans or other debt obligations, (c) payments made as a reimbursement of costs incurred, such as for patent prosecution costs, (d) amounts received to cover research and development activities related to actual or potential LICENSED PRODUCTS or LICENSED PROCESSES after the effective date of the sublicense agreement, and (e) amounts attributable to intellectual property other than the LICENSED PATENTS, as follows:
1) [XXX] if the sublicense is entered into on or after the EFFECTIVE DATE and before [XXX];
2) [XXX] if the sublicense is entered into at or after [XXX] and before [XXX]; and
3) [XXX] if [XXX] into at or after [XXX].
Sublicensing Fees. AST shall notify Licensor in writing and pay to Licensor a fee of XX dollars (USD $XX) for each Sublicense Agreement that AST enters into with a Member, within forty-five (45) days following the date of such Sublicense Agreement. [LANGUAGE TO BE USED ONLY IF BROKER IS INVOLVED] Licensor hereby instructs AST to wire each such payment in accordance with the following wire instructions: Amount: Name of Bank: Bank Address: ABA Check Routing Number: Account Number: Name on Account: [IF A FOREIGN ENTITY, ADD THE BELOW] SWIFT Code: IBAN Number: Amount: Name of Bank: Bank Address: ABA Check Routing Number: Name on Account: Account Number: [IF A FOREIGN ENTITY, ADD THE BELOW] SWIFT Code: IBAN Number:
Sublicensing Fees. In the event that the Licensee sublicenses the Product during the License Period, Licensee shall pay to the Licensor, on a monthly basis and within fifteen days of the end of each calendar month during the License Period, a sublicensing fee in the amount of Five Cents ($0.05) per each 100 capsules of Product sold by any sublicensee of the Licensee.
Sublicensing Fees. In further consideration of the license granted hereunder, Prothena shall pay to UHN the following percentage of Sublicensing Revenue received in consideration for Sublicense(s) of the Licensed Intellectual Property:
(a) [***] of all Sublicensing Revenue received by Prothena and Affiliate(s) under any Sublicense [***];
(b) [***] of all Sublicensing Revenue received by Prothena and Affiliate(s) under any Sublicense [***]; collectively “Sublicensing Fee”.
Sublicensing Fees. Licensee will pay Xxxxxx and Xxxxxxxx 18.75% of Sublicensing Revenue, and Licensee will pay Foundation 6.25% of Sublicensing Revenue (Licensor will in the aggregate receive 25% of the Sublicensing Revenue, and such amount will be considered “Sublicensing Fees”).
Sublicensing Fees. In the event that AUT sublicenses the Product during the License Period, including any renewals thereto, AUT shall pay to Lundqvist, on a monthly basis and within forty five (45) days of the end of each calendar month during the License Period and any renewals thereto, a sublicensing fee in the amount of twelve percent (12%) of gross profits realized by AUT's sublicense of the Product.
Sublicensing Fees. Sublicensing Fees shall mean any payments received by Licensee (other than royalty payments or reimbursement of research or development expenses) as consideration for the granting of a Covered Sublicense, net of the value of any rights, interests or other consideration (including, without limitation, equity interests in Licensee) provided by Licensee to Sublicensee other than the sublicense to the Licensed Patents or Licensed Data.
